FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to surgery, and concerns treating the patients with critical ischemia of lower extremities of various geneses. That is ensured by a complex background therapy of lower extremities involving intravenous drop introduction of SEROTONIN ADIPINATE 10 mg/day for 10 days with Mexicor added. For the first five days, Mexicor is administered once a day intra-arterially through a femoral catheter on an affected side in a daily dose 800 mg at rate 200 mg/hour. For the following five days, the intravenous drop introduction of Mexicor is performed by the schedule: at 6 o'clock - 200 mg; at 1400 - 300 mg; at 2200 - 300 mg dissolved in physiologic saline 100 ml at introduction rate 200-300 mg/hour.
EFFECT: method provides effective treatment and reduced number of failures in the form of amputation of the extremity due to improvement of microcirculation and elimination of reperfusion disorders in ischemic tissues.
2 ex, 4 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING ISCHEMIC OR NEUROISCHEMIC FORMS OF DIABETIC FOOT SYNDROME | 2005 |
|
RU2311206C2 |
METHOD FOR TREATING CRITICAL ISCHEMIA OF INFERIOR LIMBS | 2001 |
|
RU2201262C2 |
METHOD FOR TREATING ISCHEMIC FORM OF DIABETIC FOOT SYNDROME ALONG WITH DISTAL TYPE OF LESION IN ARTERIES OF INFERIOR LIMBS | 2005 |
|
RU2308945C2 |
METHOD OF TREATING PATIENTS WITH OBLITERATING ARTERIAL SCLEROSIS OF LOWER EXTREMITIES COMBINED WITH ISCHEMIC HEART DISEASE | 2013 |
|
RU2525157C1 |
METHOD OF TREATING PATIENTS WITH POSTOPERATIVE LYMPHORRHEA | 2023 |
|
RU2807874C1 |
METHOD FOR PREVENTING AND TREATING HEPATIC CONSEQUENCES OF ISCHEMIA | 2011 |
|
RU2456678C1 |
METHOD OF TREATING PATIENTS WITH SEVERE FORMS OF REPERFUSION SYNDROME COMPLICATED BY POSTOPERATIVE LYMPHORRHEA | 2023 |
|
RU2808921C1 |
METHOD OF TREATING PATIENTS WITH REPERFUSION SYNDROME | 2023 |
|
RU2807876C1 |
METHOD OF TREATING PATIENTS WITH SEVERE FORMS OF REPERFUSION SYNDROME | 2023 |
|
RU2807877C1 |
METHOD OF TREATING CHRONIC LOWER LIMB ISCHEMIA OF IIB - IV STAGES | 2007 |
|
RU2351334C1 |
Authors
Dates
2011-06-20—Published
2010-03-22—Filed